Douglas Twenefour

Who Douglas Twenefour is

Douglas Twenefour is a Specialist Dietitian with over 15 years of clinical experience who serves as Head of Clinical at Diabetes UK, the UK's leading diabetes patient, healthcare professional and research charity. He is also an Associate Lecturer at London Metropolitan University. Twenefour co-chaired the 2018 Diabetes UK nutrition guidelines working group and served as co-chair of the SACN joint working group investigating lower carbohydrate diets for adults with type 2 diabetes. He was a member of the international expert group convened by the American Diabetes Association that produced the consensus report on the definition and interpretation of remission in type 2 diabetes, published across four major journals in 2021. He is regularly quoted in UK press on diabetes treatment access, NICE guidance, and the clinical management of type 2 diabetes.

References for this biography

1. 1.We welcome NICE guidelines expanding access to newer and more effective type 2 medications | Diabetes UK — Confirms current title 'Head of Clinical at Diabetes UK' and his public spokesperson role on NICE type 2 diabetes treatment guidance (February 2026)
2. 2.Douglas Twenefour – Diabetes Africa — Confirms role as Specialist Dietitian with 15+ years' experience, Head of Care at Diabetes UK, Associate Lecturer at London Metropolitan University, co-chair of SACN working group, co-chair of 2018 Diabetes UK nutrition guidelines, and involvement in international diabetes remission consensus
3. 3.Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes | Diabetes Care — Establishes Twenefour as a named co-author of the international ADA-convened consensus report on type 2 diabetes remission (2021)
4. 4.Lower carbohydrate diets for adults with type 2 diabetes – SACN/Diabetes UK report — Official UK government document confirming Twenefour as co-chair of the SACN/Diabetes UK joint working group on lower carbohydrate diets
5. 5.Douglas Twenefour RD (@dtwenefour) / X — Self-identifies as 'Dietitian, Head of Clinical · @DiabetesUK', confirming X account ownership and current title
6. 6.NICE draft guidance 'biggest shake-up' to type 2 diabetes treatment in a decade – The Pharmaceutical Journal — Independent press source quoting Twenefour as 'head of clinical at Diabetes UK' on NICE type 2 diabetes draft guidance (August 2025)
7. 7.How to find us – Diabetes UK Shop — Confirms Diabetes UK London head office address: Wells Lawrence House, 126 Backchurch Lane, London E1 1FH

Notable achievements

• Co-chaired the SACN/Diabetes UK joint working group on lower carbohydrate diets for adults with type 2 diabetes, producing government-level dietary guidance. Source ↗
• Named author on the international consensus report defining remission in type 2 diabetes, published in Diabetes Care (October 2021) and co-published across four major journals. Source ↗
• Co-chaired the Diabetes UK 2018 nutrition guidelines working group for the prevention and management of diabetes. Source ↗

What Douglas Twenefour has said

• “Providing earlier access to vital drugs that protect the heart and kidneys from serious diabetes-related complications is a major step towards reducing the harm caused by this relentless condition.”

  head of clinical at Diabetes UK · Diabetes · 30 Sept 2026 · NICE widens access to SGLT-2 inhibitors and GLP-1s in updated type 2 diabetes guidance ↗

• “For some, especially those with additional care needs, moving from daily insulin injections to a once-weekly option could help manage their diabetes more easily, improving their quality of life.”

  head of clinical at Diabetes UK · Diabetes · 30 Sept 2026 · Weekly type 2 diabetes jab could replace daily injections ↗

• “Around 6.9 million people in the UK are at increased risk of type 2 diabetes, but taking small steps can make a big difference. Diabetes UK's free online Know Your Risk tool can help you understand your risk in just a few minutes, and offers advice on how to reduce it if needed.”

  Head of Clinical at Diabetes UK · Diabetes · 30 Sept 2026 · Over 6 in 10 people have not checked their type 2 diabetes risk, our research shows ↗

• “Around 6.9 million people in the UK are at increased risk of type 2 diabetes, but taking small steps can make a big difference. Diabetes UK's free, online Know Your Risk tool can help you understand your risk in just a few minutes, and offers advice on how to reduce it if needed.”

  Head of Clinical at Diabetes UK · Diabetes · 10 Sept 2026 · New research reveals over four in ten Brits have never thought about their risk of developing type 2 diabetes ↗

• “For some, especially those with additional care needs, moving from daily insulin injections to a once-weekly option could help manage their diabetes more easily, improving their quality of life.”

  head of clinical at Diabetes UK · Diabetes · 27 Aug 2026 · Weekly type 2 diabetes jab could replace daily injections ↗

• “For some, especially those with additional care needs, moving from daily insulin injections to a once-weekly option could help manage their diabetes more easily, improving their quality of life.”

  Head of clinical at Diabetes UK · Diabetes · 27 Aug 2026 · NICE recommends weekly insulin jab for type 2 diabetes in final draft guidance ↗

• “For some, especially those with additional care needs, moving from daily insulin injections to a once-weekly option could help manage their diabetes more easily, improving their quality of life.”

  head of clinical at Diabetes UK · Diabetes · 27 Aug 2026 · NICE approves weekly insulin injection for patients with type 2 diabetes ↗

• “This recommendation is an important step towards giving people with type 2 diabetes greater flexibility in how their condition is managed.”

  head of clinical at Diabetes UK · Diabetes · 27 Aug 2026 · Lilly’s long-acting insulin wins NICE blessing ahead of potential UK approval ↗

• “Around 6.9 million people in the UK are at increased risk of type 2 diabetes, but taking small steps can make a big difference.”

  head of clinical at Diabetes UK · Diabetes · 10 Aug 2026 · St Helens residents urged to check their type 2 diabetes risk ↗

Recent social activity

• Wow!

  x.com ↗

• Wishing him a speedy recovery 🙏

  x.com ↗

Where Douglas Twenefour has been quoted

1. Our response to serious supply issues of drugs for people with type 2 diabetesdiabetes.org.uk · 30 Sept 2026
2. NICE widens access to SGLT-2 inhibitors and GLP-1s in updated type 2 diabetes guidancepharmaceutical-journal.com · 30 Sept 2026
3. Weekly type 2 diabetes jab could replace daily injectionsbbc.com · 30 Sept 2026
4. Over 6 in 10 people have not checked their type 2 diabetes risk, our research showsdiabetes.org.uk · 30 Sept 2026
5. New research reveals over four in ten Brits have never thought about their risk of developing type 2 diabetesdiabetestimes.co.uk · 10 Sept 2026
6. Weekly type 2 diabetes jab could replace daily injectionsbbc.co.uk · 27 Aug 2026
7. NICE recommends weekly insulin jab for type 2 diabetes in final draft guidancenursinginpractice.com · 27 Aug 2026
8. NICE approves weekly insulin injection for patients with type 2 diabetespulsetoday.co.uk · 27 Aug 2026
9. Lilly’s long-acting insulin wins NICE blessing ahead of potential UK approvalfiercepharma.com · 27 Aug 2026
10. St Helens residents urged to check their type 2 diabetes risksthelensstar.co.uk · 10 Aug 2026

Related media coverage

Recent UK press coverage of their topics — not necessarily citing them directly.

• Severe Type 1 Diabetes Onset Linked to Later ComplicationsEMJ
• Tazbentetol shows retinal neuroprotection potential in diabetic mouse modelDrug Target Review
• UK start-up takes on Americans with cheaper diabetes devicesThe Times

Contact & links

• Xhttps://x.com/dtwenefourpublished here ↗
• LinkedInhttps://uk.linkedin.com/in/douglas-twenefour-rd-3b6a3644
• Staff pagehttps://www.diabetes.org.uk/about-us/contact-us
• ORCIDhttps://orcid.org/0000-0003-1282-6814published here ↗

Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.